Sight Sciences to Present at Gilmartin Group’s Inaugural Emerging Growth Companies Showcase


Enter Wall Street with StreetInsider Premium. Claim your one week free trial here.


MENLO PARK, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eye care technology company focused on developing and commercializing innovative solutions to transform care and improve Patient Life, today announced plans to present at Gilmartin Group’s upcoming inaugural Emerging Growth Companies Showcase, which will take place virtually. Members of management are due to present Wednesday, August 31, 2022 at 2:30 p.m. ET.

Interested parties can access a live webcast of the presentation directly by following this link. An archived webcast of the presentation will be available in the “Investors” section of the Sight Sciences website at https://www.sightsciences.com/ following the event.

Parties interested in registering for the inaugural Gilmartin Group Emerging Growth Companies presentation can do so by following this link.

About vision scienceSight Sciences is an eye care technology company focused on developing and commercializing innovative solutions to transform care and improve the lives of patients. By using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that improve patient care and supplant outdated conventional approaches. The Company’s OMNI® Surgical System is a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the world’s leading cause of irreversible blindness. The company’s TearCare® System is 510(k) cleared for the application of localized heat therapy in adult patients with evaporative dry eye due to meibomian gland dysfunction (MGD), enabling in-office elimination of blockages of the glands by doctors to treat the root cause of dry eye. The Company’s SION™ Surgical Instrument is a manually operated device used in ophthalmic surgical procedures to excise the trabecular meshwork.

For more information, visit www.sightsciences.com.

OMNI® and TearCare® are registered trademarks of Sight Sciences. SION™ is a trademark of Sight Sciences. © 2022 Sight Sciences. All rights reserved.

Investor contacts:Philip TaylorGilmartin Group415.937.5406[email protected]

main logo

Source: Vision Sciences, Inc.

Comments are closed.